Location Basel-Landschaft, Switzerland, Europe Regions Europe, Middle East, and Africa (EMEA) Gender Male
LinkedIn View on LinkedIn
Prof. Dr. Friedrich Metzger, a scientist and co-founder of Versameb, has an over 18 years’ experience in R&D both in pharma and biotech. Previously, Friedrich was Head of Discovery, Rare Diseases at Roche, Basel, where he was responsible for a portfolio of highly innovative development programs. He led preclinical activities for Evrysdi™
(risdiplam), a groundbreaking oral therapy for spinal muscular atrophy which was very recently approved. Friedrich is also Professor in Neurobiology at the University of Freiburg, Germany, and holds a PhD degree in pharmacology from the University of Tübingen, Germany.
